In the present study, we found that ox‐LDL, a well‐documented risk contributor for atherosclerosis,15 promoted HASMC proliferation and migration, and the enhanced proliferation and migration in ox‐LDL‐treated HASMCs was accompanied by the up‐regulation of TNK2‐AS1. This evidence concerns the gene TNK2 and atherosclerosis.